Back to Dividend Stocks
Roivant Sciences Ltd (ROIV) logo

Roivant Sciences Ltd

S&P 500

ROIV/Healthcare · Biotechnology/NASDAQ

Stock Price

$34.02

Stock Price$34.02P/E1.9MCap22.5BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

ROIV does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company that develops transformative medicines and technologies by creating agile, focused subsidiaries called Vants. These Vants target specific therapeutic areas, including autoimmune diseases through Immunovant, severe autoimmune conditions via Priovant, and pulmonary diseases with Pulmovant. The company applies technology across drug discovery, development, and commercialization to accelerate the delivery of innovative therapies to patients. Roivant Sciences Ltd. maintains a broad pipeline of investigational drugs across multiple areas such as immunology, dermatology, rare diseases, and inflammatory conditions. Notable Vants include Kinevant for rare autoimmune and inflammatory diseases, and health technology units like Datavant for healthcare data sharing and Lokavant for clinical trial optimization. Founded in 2014 and headquartered in New York City with offices in Boston and Basel, Roivant Sciences Ltd. operates as a parent to these specialized entities, aligning incentives for efficient execution in the biopharmaceutical sector.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$10.71 - $34.68

Earnings & Profitability

ROIV earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

ROIV Dividend Calculator

Total Investment

$3,402.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is ROIV's current dividend yield?
Roivant Sciences Ltd (ROIV) currently has a dividend yield of 0.00%, based on a stock price of $34.02 and an annual dividend of $0.00.
When is ROIV's next dividend payment date?
ROIV's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does ROIV pay in dividends per year?
Roivant Sciences Ltd pays dividends unknown. Annual dividend data is not yet available.
Has ROIV been increasing its dividend?
Roivant Sciences Ltd has grown its dividend at a 5-year CAGR of —.
Is ROIV's dividend safe?
Roivant Sciences Ltd has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is ROIV's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Roivant Sciences Ltd's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track ROIV Dividends with OnlyDividends

What will ROIV actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.